ArticleClinical endocrinology2025
Determination of Androgen Bioactivity by an In Vitro Assay During Pubertal Transition in Healthy Boys.
Article in Clinical endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveTo describe the bioactivity of circulating androgens during pubertal transition as determined by an in vitro bioassay assessing androgen receptor (AR) activation, and to compare these findings with circulating concentrations of total testosterone (total T) measured by LC-MS/MS.
methodsThis longitudinal study included ten healthy boys from the Copenhagen Puberty Study II conducted from 2006 to 2011. MAIN OUTCOME MEASURE(S): Androgen bioactivity and serum concentrations of total T were measured by an in vitro bioassay and LC-MS/MS with limits of detection of 0.3 and 0.01 nmol/L, respectively. The serum concentration of free testosterone (free T) was calculated using the Vermeulen equation. Pubertal onset was defined as testicular enlargement ≥ 4 mL, assessed by palpation.
resultsAndrogen bioactivity was unmeasurable before puberty but measurable in nine of ten boys 0.8-1.7 years after pubertal onset. Total T and free T were measurable prepubertally in all boys and increased in two before pubertal onset. Androgen bioactivity correlated strongly with total T (r = 0.93, p < 0.001) and free T (r = 0.93, p < 0.001). ROC accuracies were 77% for androgen bioactivity, 93% for total T, and 95% for free T.
conclusionAndrogen bioactivity was undetectable before pubertal onset but measurable after in most boys, reflecting both the bioassay's lower sensitivity and potential physiological changes in androgen bioactivity during early puberty. Further studies are needed to clarify these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.